NCT06826378

Brief Summary

Impact on the quality of life (in terms of functional recovery and gastrointestinal symptoms) of segmental resection surgery in patients with intestinal endometriosis undergoing either a totally intracorporeal or extracorporeal procedure

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 14, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

February 14, 2025

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

December 3, 2024

Last Update Submit

February 11, 2025

Conditions

Keywords

EndometriosisGynaecologySurgeryAnastomosisSegmental resection

Outcome Measures

Primary Outcomes (1)

  • Impact on the quality of life (in terms of functional recovery and gastrointestinal symptoms) of segmental resection surgery in patients with intestinal endometriosis undergoing either a totally intracorporeal or extracorporeal procedure

    Evaluation by scoring the validated Low Anterior Resection Syndrome score questionnaire

    During the preoperative evaluation and at 3 months after surgery as part of the postoperative follow-up visit

Secondary Outcomes (5)

  • Detect any differences in the duration of the total operating time in the two different treatments

    During surgery

  • Duration of hospitalisation in the two different types of surgery

    From date of surgery until the discharge (0-30 days)

  • Success rate of the totally intracorporeal procedure in patients with deep endometriosis with bowel involvement undergoing segmental resection surgery

    At 3 months after surgery

  • Incidence of intra-operative complications (rectorrhagia, anastomotic dehiscence, intussusception, stenosis of the anastomosis, intraperitoneal haemorrhage, conversion to laparotomic surgery) and evaluate any differences in these between the two groups

    At 3 months after surgery

  • Incidence of post-operative complications in the two different surgical treatments

    Within 3 months of surgery

Eligibility Criteria

Age18 Years - 54 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with deep endometriosis with suspected bowel involvement and intraoperative indication for segmental resection

You may qualify if:

  • Women between 18 and 54 years of age
  • Diagnosis, by instrumental examination such as transvaginal ultrasound, of deep endometriosis with suspected intestinal involvement
  • Intraoperative indication for segmental resection for intestinal endometriosis
  • Obtaining informed consent for study participation and data processing

You may not qualify if:

  • Patients with a known concomitant inflammatory bowel syndrome (inflammatory bowel syndrome)
  • Patients undergoing emergency/emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, 40138, Italy

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Diego Raimondo, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Diego Raimondo, MD

CONTACT

Stefano Ferla, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2024

First Posted

February 14, 2025

Study Start

February 1, 2025

Primary Completion

February 1, 2026

Study Completion

May 1, 2026

Last Updated

February 14, 2025

Record last verified: 2024-10

Locations